Literature DB >> 3825955

Plasma norepinephrine levels in infants and children with congestive heart failure.

R D Ross, S R Daniels, D C Schwartz, D W Hannon, R Shukla, S Kaplan.   

Abstract

To characterize the sympathetic nervous system response to congestive heart failure (CHF) in infants and children, plasma catecholamine levels were measured in 102 subjects undergoing routine cardiac catheterization (mean age 3.3 years, range 0.1 to 14.7), including 61 with left-to-right shunts. Plasma norepinephrine levels were significantly higher (p less than 0.0001) in children with CHF than in those without CHF. A highly significant association (p less than 0.0001) was found between the level of plasma norepinephrine and severity of CHF symptoms. This relation was found for CHF secondary to lesions producing a left-to-right shunt and CHF resulting from primary myocardial dysfunction. In congenital lesions with a left-to-right shunt, plasma norepinephrine levels correlated well with size of the shunt (Qp/Qs) (r = 0.75, p less than 0.001) and degree of pulmonary arterial hypertension (r = 0.70, p less than 0.001). Elevation of plasma norepinephrine concentrations in infants and children are seen with severe CHF regardless of its origin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3825955     DOI: 10.1016/0002-9149(87)91118-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

1.  Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy.

Authors:  P Acar; P Merlet; L Iserin; D Bonnet; D Sidi; A Syrota; J Kachaner
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease.

Authors:  R Kozlik; H H Kramer; H Wicht; A Krian; J Ostermeyer; D Reinhardt
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

3.  Enalapril in infants with single ventricle: results of a multicenter randomized trial.

Authors:  Daphne T Hsu; Victor Zak; Lynn Mahony; Lynn A Sleeper; Andrew M Atz; Jami C Levine; Piers C Barker; Chitra Ravishankar; Brian W McCrindle; Richard V Williams; Karen Altmann; Nancy S Ghanayem; Renee Margossian; Wendy K Chung; William L Border; Gail D Pearson; Mario P Stylianou; Seema Mital
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

Review 4.  The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision.

Authors:  Robert D Ross
Journal:  Pediatr Cardiol       Date:  2012-04-05       Impact factor: 1.655

Review 5.  Future pharmacologic agents for treatment of heart failure in children.

Authors:  Brady S Moffett; Anthony C Chang
Journal:  Pediatr Cardiol       Date:  2006-08-23       Impact factor: 1.655

6.  Anatomic Repair of Congenitally Corrected Transposition of the Great Arteries: Single-Center Intermediate-Term Experience.

Authors:  Shagun Sachdeva; Roni M Jacobsen; Ronald K Woods; Michael E Mitchell; Joseph R Cava; Nancy S Ghanayem; Peter C Frommelt; Peter J Bartz; James S Tweddell
Journal:  Pediatr Cardiol       Date:  2017-09-16       Impact factor: 1.655

7.  Diagnostic and Prognostic Value of Plasma Levels of Cardiac Myosin Binding Protein-C as a Novel Biomarker in Heart Failure.

Authors:  Doaa El Amrousy; Hossam Hodeib; Ghada Suliman; Nahed Hablas; Eman Ramadan Salama; Ahmed Esam
Journal:  Pediatr Cardiol       Date:  2016-11-23       Impact factor: 1.655

Review 8.  Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure?

Authors:  Luke A Bruns; Charles E Canter
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy.

Authors:  Shelley D Miyamoto; Brian L Stauffer; Stephanie Nakano; Rebecca Sobus; Karin Nunley; Penny Nelson; Carmen C Sucharov
Journal:  Eur Heart J       Date:  2012-07-26       Impact factor: 29.983

10.  Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle.

Authors:  Daphne T Hsu; Seema Mital; Chitra Ravishankar; Renee Margossian; Jennifer S Li; Lynn A Sleeper; Richard V Williams; Jami C Levine; Brian W McCrindle; Andrew M Atz; Darlene Servedio; Lynn Mahony
Journal:  Am Heart J       Date:  2009-01       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.